In a recent report, Morgan Keegan has lowered the price target on Emeritus ESC from $31.00 to $29.00 but maintained their Outperform rating after 1Q results were shy of Morgan Keegan's estimates.
In the report, Morgan Keegan said, "We continue to believe Emeritus is well-positioned to take advantage of gradually improving occupancy and rate coupled with growing demand and fairly static supply."
ESC closed yesterday at $23.21.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsEmeritus CorporationHealth CareHealth Care FacilitiesMorgan Keegan
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in